Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α
António Almeida (with Raquel Alves). 2020. JOURNAL OF TRANSLATIONAL MEDICINE